Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment
Y Huang, X Guo, Y Wu, X Chen, L Feng, N ** review
M Rueda-Fernández, L Melguizo-Rodríguez… - Drug Discovery …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new disease that has
led to a worldwide pandemic, resulting in millions of deaths and a high economic burden …
led to a worldwide pandemic, resulting in millions of deaths and a high economic burden …
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
Recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for
hematological diseases are at risk of severe disease and death from COVID-19. To …
hematological diseases are at risk of severe disease and death from COVID-19. To …
Cellular and humoral immunity to SARS‐CoV‐2 infection in multiple sclerosis patients on ocrelizumab and other disease‐modifying therapies: a multi‐ethnic …
I Kister, Y Patskovsky, R Curtin, J Pei… - Annals of …, 2022 - Wiley Online Library
Objective The objective of this study was to determine the impact of multiple sclerosis (MS)
disease‐modifying therapies (DMTs) on the development of cellular and humoral immunity …
disease‐modifying therapies (DMTs) on the development of cellular and humoral immunity …
In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose
P Stolfi, F Castiglione, E Mastrostefano… - Frontiers in …, 2022 - frontiersin.org
Background The immune response to adenoviral COVID-19 vaccines is affected by the
interval between doses. The optimal interval is unknown. Aim We aim to explore in-silico the …
interval between doses. The optimal interval is unknown. Aim We aim to explore in-silico the …
Timing of SARS-CoV-2 vaccination matters in people with multiple sclerosis on pulsed anti-CD20 treatment
C Woopen, M Dunsche, R Haase… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Our objective was to investigate cellular and humoral immune
responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in …
responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in …
Dynamics of neutralizing antibody and T-cell responses to SARS-CoV-2 and variants of concern after primary immunization with CoronaVac and booster with …
W Jantarabenjakul, P Sodsai, N Chantasrisawad… - Vaccines, 2022 - mdpi.com
Inactivated SARS-CoV-2 vaccine (CoronaVac) is commonly used in national immunization
programs. However, the immune response significantly declines within a few months. Our …
programs. However, the immune response significantly declines within a few months. Our …
Correlation between in vitro neutralization assay and serological tests for protective antibodies detection
MA Bonifacio, R Laterza, A Vinella, A Schirinzi… - International Journal of …, 2022 - mdpi.com
Serological assays are useful in investigating the development of humoral immunity against
SARS-CoV-2 in the context of epidemiological studies focusing on the spread of protective …
SARS-CoV-2 in the context of epidemiological studies focusing on the spread of protective …